Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Nanosonics Limited ( (AU:NAN) ) has issued an announcement.
Nanosonics Limited has achieved significant regulatory milestones for its CORIS endoscope cleaning system, securing registrations in Australia, the EU, and the UK. These certifications enable the company to commence a Controlled Market Release in the UK, Ireland, and Australia starting January 2026, marking a crucial step in its commercialisation strategy and potentially strengthening its market position in infection prevention solutions.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.43 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is a leader in infection prevention solutions, focusing on innovative technologies to enhance patient safety and reduce infection risks. The company specializes in the development and commercialization of advanced cleaning systems for medical devices, particularly targeting the healthcare industry with products like the CORIS system.
Average Trading Volume: 604,605
Technical Sentiment Signal: Buy
Current Market Cap: A$1.28B
Find detailed analytics on NAN stock on TipRanks’ Stock Analysis page.